4o1b: Difference between revisions
No edit summary |
No edit summary |
||
| Line 8: | Line 8: | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4o1b FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4o1b OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4o1b RCSB], [http://www.ebi.ac.uk/pdbsum/4o1b PDBsum]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4o1b FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4o1b OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4o1b RCSB], [http://www.ebi.ac.uk/pdbsum/4o1b PDBsum]</span></td></tr> | ||
</table> | </table> | ||
== Function == | |||
[[http://www.uniprot.org/uniprot/NAMPT_HUMAN NAMPT_HUMAN]] Catalyzes the condensation of nicotinamide with 5-phosphoribosyl-1-pyrophosphate to yield nicotinamide mononucleotide, an intermediate in the biosynthesis of NAD. It is the rate limiting component in the mammalian NAD biosynthesis pathway (By similarity). | |||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| Line 21: | Line 23: | ||
</StructureSection> | </StructureSection> | ||
[[Category: Nicotinamide phosphoribosyltransferase]] | [[Category: Nicotinamide phosphoribosyltransferase]] | ||
[[Category: Brillantes, B | [[Category: Brillantes, B]] | ||
[[Category: Coons, M | [[Category: Coons, M]] | ||
[[Category: Oh, A | [[Category: Oh, A]] | ||
[[Category: Wang, W | [[Category: Wang, W]] | ||
[[Category: Transferase-transferase inhibitor complex]] | [[Category: Transferase-transferase inhibitor complex]] | ||